© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Imidocarb dipropionate came into focus in the 1960s. Researchers were searching for effective measures against protozoal diseases ravaging livestock. This compound stood out in trials on cattle and dogs suffering from babesiosis and other tick-borne illnesses. Pharmaceutical producers quickly moved to commercialize it, spotting a need for something more reliable than early organochlorines and arsenic-based treatments that often left animals worse than before. Watching rural practice change after its introduction, those in the veterinary field saw survival rates improve. Its journey from a research chemical into a mainstay in animal healthcare reflects an era of innovation, growing awareness about livestock welfare, and the steady push for pharmaceuticals that do more than just mask symptoms.
Imidocarb dipropionate, sometimes seen as imidocarb bispropionate, belongs to the carbanilide family. The compound finds its home in the veterinary world, delivered as a clear, colorless or faintly yellow injectable solution. With a practical 120 mg/ml strength, it targets protozoal agents in red blood cells such as Babesia and Anaplasma species. Companies package it under names like Imizol and Carbesia, each promising to break the cycle of infection that can devastate herds. For ranchers and veterinarians, it means fewer losses and more predictable production cycles.
This compound takes on the form of a white to off-white crystalline powder, soluble in water and alcohol. It carries a molecular formula of C19H20N6O2•2C3H6O2, displaying stability at room temperature and moderate humidity. The slightly bitter taste and low volatility lower accidental inhalation risks in handling. Its melting point sits around 105-108°C, which lines up with reliable storage and manufacturability. In daily practice, these features matter less to the livestock owner but make all the difference in pharmacies preparing consistent dosages for field use. Stability tests over the years show strong shelf life, giving peace of mind from warehouse to farmyard.
Pharmaceutical guidelines demand clear labeling of imidocarb’s content, strength, and administration routes. Each vial comes with a batch number and expiry date, plus a list of other ingredients to shield users from allergenic surprises. The injectable solution ships in glass vials to prevent chemical interaction, and regulatory authorities like the FDA and EMA require clear warnings about potential side-effects—such as pain at injection sites. Labels lay out withdrawal times for treated animals, critical for maintaining safe meat and milk supplies. Transparent communication from drug makers to field users is essential in keeping both animal and human populations safe.
Modern synthesis of imidocarb dipropionate takes a multi-stage route starting with the condensation of aromatic diamines and carbamoyl chlorides. Once the imidocarb base emerges, chemists introduce propionic acid to form the dipropionate salt, which increases water solubility and furthers bioavailability. Stringent controls monitor temperature, pH, and purity, with high-performance liquid chromatography ensuring each batch meets veterinary standards for injectables. This complexity resists efforts by counterfeiters and secures farmer trust in what they inject into their stock.
Its structure resists easy breakdown under typical storage conditions but can hydrolyze in extreme acidic or basic environments. Scientists have explored slight modifications to the molecule, searching for derivatives that leverage the parent compound’s anti-protozoal potency while nailing down faster elimination or lower toxicity. Research tackles the challenge of balancing chemical resilience with safe metabolism—critical for any veterinary medication distributed at scale. Direct conjugation with various esters expands application prospects beyond basic injection, bringing new profiles for oral or topical delivery into experimental studies. Any small change in the chemical backbone gets scrutinized both for added benefit and for new risks.
Across different regions and manufacturers, imidocarb dipropionate has picked up a handful of alternate labels: imidocarb propanedioate, imizol, carbesia, imizole, and several others intended to distinguish company offerings. Vets in rural clinics sometimes use shorthand, simply calling it “imidocarb,” but supply chain documentation leans on full chemical names to reduce confusion. Trademarked varieties may contain slight tweaks in fillers or preservatives, but the active component stays consistent worldwide. Accurate nomenclature remains vital for avoiding adverse effects and achieving the desired therapeutic outcome.
Healthcare workers administering this medication rely on strict protocols. Sterile technique—new needles, sanitized vials, proper disposal—keeps animals safe from secondary infection. Training covers not just dosing, but reactions like salivation, tremors, or even rare cases of acute anaphylaxis, since these events, although statistically minimal, demand immediate response. Operators observe withdrawal periods for food-producing animals, paying close attention to official waiting times before slaughter or milk collection. Veterinary boards and international regulators set tight limits on residue levels, and routine field checks ensure compliance. Such discipline builds community trust and long-term safety for everyone down the food chain.
Imidocarb finds heavy use in treating babesiosis and anaplasmosis in cattle, as well as canine babesiosis across Europe, Africa, and parts of Asia where tick-borne protozoa maintain strongholds. Livestock in subtropical regions face immense exposures, and well-timed injections mean the difference between large outbreaks and controlled herd health. Ranchers dealing with stressed or pregnant animals often turn to this compound, appreciating the combination of targeted action and a well-documented side effect profile. Beyond farm gates, some zoos employ imidocarb to protect endangered ungulates from blood parasites, underscoring its wider value for animal health. Regulatory bodies keep tight watch over off-label uses, demanding robust evidence before expanding its pharmaceutical status.
The latest research looks at multi-drug approaches, combining imidocarb with antibiotics or antiprotozoals to fend off resistant pathogens. Scientists track emerging strains of Babesia and Theileria that don’t respond to older protocols, urging a fresh review of dosing schedules and administration routes. Technological leaps in genomic analysis let researchers identify mutations in protozoal enzymes, paving the way for smarter adjustments to the molecule. Field studies run side by side with laboratory work, aiming to trim dosage without sacrificing potency, all while reducing the risk of residual buildup in edible tissues. Funding agencies reward proposals connecting chemical innovation to tangible field results, pushing pharmaceutical companies to share promising pipeline developments and trial outcomes.
Extensive toxicology studies map out the realities and limits of imidocarb’s benefits. Acute toxicity often surfaces as transient cholinergic symptoms—salivation, sweating, gastrointestinal upset—but most cases resolve without intervention. Doses far above therapeutic levels can compromise kidney and liver function, so producers reinforce maximum dose limits in training workshops. Long-term studies in beagles and dairy cows track tissue residues and potential genetic impacts, with current data supporting its continued use within regulatory limits. Maternal transfer studies get close attention as well, assessing whether treated livestock pass chemical traces into offspring or milk. This information offers valuable guidance for international trade partners screening imports for veterinary drug residues.
Across the global veterinary landscape, the future for imidocarb dipropionate depends on innovation and vigilance. Shifting weather patterns mean tick-borne diseases will hit new areas harder, fueling expanding demand for anti-protozoals that combine speed, reliability, and a proven record. Pharmaceutical companies explore ways to increase safety for pregnant or lactating animals, knowing that producers want more than a one-size-fits-all answer. Researchers seek new formulations for oral dosing, hoping to broaden ease of administration for large herds. Any expansion must pass both regulatory and ethical scrutiny, with oversight agencies setting benchmarks that others follow. Animal health professionals keep pushing for reduced toxicity and shorter withdrawal periods, recognizing growing consumer concerns over residues in food. The challenge stays clear: keep refining, keep testing, and maintain transparency at every step.
Imidocarb dipropionate, sometimes called imidocarb bispropionate, sits firmly in the toolbox for veterinarians fighting tick-borne and protozoal diseases in animals. This isn’t some new experimental drug—decades of use have shaped its reputation as a trusted treatment for serious infections like babesiosis and ehrlichiosis, especially in dogs, cattle, and horses. People who work with livestock or companion animals see just how quickly outbreaks of these diseases can wipe out a herd or make a beloved pet gravely ill. Without proper intervention, tick-borne illnesses often bring anemia, weakness, and, if you catch it too late, sometimes death.
Imidocarb targets parasites at the root. Babesia and similar organisms may seem small on the microscope slide, but they cause big problems once inside the blood. Imidocarb doesn’t just slow them down; it attacks their ability to survive and replicate, disrupting protein synthesis and undermining their metabolism. This translates to a direct impact—fewer parasites, less disease, and a real chance for recovery. Having seen ranchers struggle with recurring tick problems, it’s plain that access to imidocarb often spells the difference between hope and frustration when traditional methods fail to control an outbreak.
There’s no victory in using drugs blindly. Imidocarb is potent, and misuse carries risks. Some animals experience pain at the injection site, and, just as importantly, overuse risks building resistance in the parasite populations. That puts future animals in danger. Growing up around working dogs and hearing from veterinarians about drug side effects made it clear that smart use isn’t just a guideline—it’s a responsibility. Imidocarb also leaves residues in animal tissue for a while, which means following withdrawal times is critical before milk or meat can re-enter the human food supply. Families who rely on these products trust farmers and vets to make safe choices, upholding both animal welfare and public health.
Antimicrobial resistance isn’t just a human issue; animals feel the effects too. Imidocarb remains effective for now, but improper dosages or using the drug for conditions it doesn’t treat add pressure on the parasites to evolve defenses. This turns a winning tool into a blunt instrument. Investing in regular tick control—keeping pastures clean, using suitable repellents, and educating animal owners on best practices—forms the backbone of long-term protection. Lab testing before administering any antiparasitic drug helps match treatment to actual infection, avoiding unnecessary use and slowing resistance buildup.
Preventing babesiosis and related illnesses calls for more than fast prescriptions. Tick control strategies go hand in hand with sound veterinary care. Rotating grazing areas, maintaining fencing that keeps wildlife out, and checking animals for ticks reduce disease risk at the source. Vets also encourage vaccination if available, since a healthy immune system stands a better chance both of resisting infection and recovering if exposed. The growing popularity of telemedicine now means animal owners can consult veterinary experts for early advice, stopping problems before they escalate. Community education, tighter farm management, and responsible drug stewardship all play a part in making drugs like imidocarb remain useful for the next generation of animals and the people who care for them.
Imidocarb dipropionate is a go-to drug for treating tick-borne diseases in animals, especially babesiosis and anaplasmosis. In practice, its strength can’t be denied, but it doesn’t mean the approach is one-size-fits-all. Dosage and how you give the drug make all the difference for good results and avoiding harm.
Most veterinarians use imidocarb at 1.2 mg/kg for anaplasmosis and 2.5-3.0 mg/kg for babesiosis. That’s based on body weight, and even though the labels carry those figures, the situation guides the dose more often than routine. For example, in cattle fighting babesiosis, the higher end of the range—about 3 mg per kilo—gets chosen. Repeat doses two weeks apart can be necessary for stubborn infections.
The most effective way to give imidocarb dipropionate is by deep intramuscular injection. Subcutaneous injection is possible too, but deep into the muscle is the route that delivers consistent blood levels. Experience shows that reactions at the injection site can develop, so choosing a spot with good muscle mass matters. Avoiding stress on the animal helps, as the shot can sting, especially for the higher doses.
Imidocarb does more than beat parasites for the moment. It can leave behind residues, so the route and dose affect how long those residues stick around in meat or milk. That isn’t some minor headache either; food safety rests on asking not just “Does it cure?” but also “When can you slaughter or milk safely after use?” Keeping to withdrawal periods—often 21 days or more for meat in cattle—helps keep drug residues far from the food supply.
The drug isn’t a gentle one. In practice, it can cause sweating, drooling, diarrhea, or muscle tremors, especially if you give it too fast or in excess. Cholinergic signs tend to show up if the dose runs high. It pays to have atropine nearby, since it can reverse those reactions. Trying to calm and restrain the animal right makes the whole affair safer and less traumatic. Younger and frailer animals or those already sick may tolerate drugs like this poorly.
In veterinary clinics, sticking to recommended doses doesn’t just come from experience—it reflects clear evidence from field studies and pharmacology. I’ve watched producers overlook details around timing or injection technique and land themselves in hot water when residues show up or animals recover unpredictably. There’s real peace of mind in knowing the difference between 1.2 mg/kg and 3 mg/kg and delivering a clean, accurate injection.
Imidocarb dipropionate works. But safety demands more than simply pulling the right vial out of the fridge. It takes respect for dose, knowledge of injection routes, and ongoing attention to side effects and legal withdrawal times. Every animal, every time, deserves that level of care.
Imidocarb dipropionate steps onto the scene in veterinary medicine mostly for its effectiveness in treating diseases like babesiosis and certain tick-borne infections in animals. Its role means many farmers and pet owners have a stake in how this drug plays out, especially as resistance to older drugs rises. As handy as it is, there’s good cause to look at the risks and take them seriously. Nothing ruins a vet’s day faster than a medicine that doesn’t act the way you expect, especially for something already fighting to stay alive.
Injecting imidocarb does come with its share of side effects. Vomiting, pain at the site of injection, and mild swelling top the list. Some animals look tired or seem off their feed for a day or so after treatment. In my years dealing with livestock, I saw these minor hiccups more often than dramatic emergencies—cows or dogs might limp a bit or sulk, but usually bounced back. Still, some animals do react more strongly: colic in horses, drooling, diarrhea, or even muscle tremors.
Imidocarb’s chemical design means it can hit the liver and kidneys, stressing out animals already struggling with health problems. Bloodwork sometimes shows elevated liver enzymes or changes in kidney values, especially in older dogs. Those findings shift the risk calculator. The FDA flagged imidocarb for its possible liver impact, urging close blood monitoring in repeat uses. The take-home message: don’t just give it and walk away—keep an eye on that animal for a week or so after the shot.
Rare as it is, some dogs and horses can suffer allergic reactions. Swelling around the face, trouble breathing, or sudden collapse—these are emergencies that demand quick vet help. Most experienced handlers keep antihistamines or steroids handy when giving imidocarb, just in case. It’s not about fear, but honest preparation.
Cholinergic side effects show up thanks to imidocarb’s action as an acetylcholinesterase inhibitor—leading to signs like excessive salivation, muscle twitching, or labored breathing. Atropine can offset these symptoms, and I’ve seen this drug work like a charm after a rough reaction. The manufacture’s datasheet suggests pretreating with atropine to reduce some of these risks.
Underlying health issues raise red flags. Animals with kidney or liver disease sit at highest risk for severe complications. Young, pregnant, or lactating animals fall into a gray area; not enough data supports safe use, so many veterinarians hold back unless benefits far outweigh potential harm.
Imidocarb’s interactions create another set of challenges. Medications affecting the same organs, or those that alter how drugs get metabolized, push up toxicity risks. So, giving imidocarb to an animal already on lots of meds or recovering from recent illness deserves more thought. I’ve seen older, multi-morbid dogs struggle after getting several injections close together. Each new prescription warrants a careful review of everything that came before.
Imidocarb dipropionate fills an important gap in treating tough infections in animals. Respecting its power and watching closely for early warning signs keeps serious harm at bay. Consult your vet if you’re uncertain, and don’t ignore the small stuff—sometimes, what looks insignificant today becomes a problem tomorrow. Strong teamwork between vet, owner, and the wider farm or animal care community goes a long way. Clean records, open eyes, and honest conversations are the real backbone of safe medication use.
Ask any large animal vet about the tools used to fight parasitic diseases, and Imidocarb Dipropionate will come up fast. This isn’t something you pick up at a local pharmacy or order without a thought. Vets rely on this drug to treat babesiosis in cattle and dogs, plus other protozoal infections. The medicine’s specific action clears microscopic parasites in the bloodstream, helping sick animals get back on their feet. Still, giving this medicine calls for experience—it isn’t like using a flea collar or wormer from a pet store.
Pharmacies and agricultural suppliers require a prescription for Imidocarb Dipropionate across North America, the European Union, and Australia. Controlling access serves two purposes: keeping dangerous misuse in check and making sure dosages fit each animal’s health status.
During my time working on a ranch, vets explained why we couldn't just stockpile this drug. Too large a dose, and cattle show kidney or liver stress—I've seen steers end up worse after a well-meaning but misguided shot, dosed by someone who skipped a proper diagnosis. These mistakes stack up, hurting animals and wasting money. More worrying, parasites start surviving under-dosed medication over time. This builds resistance, making future outbreaks tougher to treat.
Buying prescription medicine is not about keeping things exclusive for vets—it's about giving animals the right help, not risking their health. Studies in the Veterinary Record and the Journal of Veterinary Internal Medicine both point out a problem: counterfeit or improperly sourced veterinary drugs flood markets online. Outdated, contaminated, or poorly manufactured drugs harm more than they heal.
It gets trickier in remote farming areas. Many farmers work far from clinics. Every decision carries cost and time, especially during an outbreak. Online platforms promise “no prescription needed,” but buying from shady sources cuts safety. When animals get the wrong treatment or drugs that don’t work, disease spreads or lingers. For anyone managing livestock, this translates into long-term losses, both in animals and economics.
Some farmers suggest that expanding telemedicine could ease the bind. Vets could consult via video, review lab results, and prescribe medicine legally, cutting down travel. Governments have begun supporting mobile veterinary clinics in remote zones, helping farmers access expert care without risky shortcuts. Responsible online pharmacies, accredited by recognized veterinary boards, bring another layer of safety as well.
People caring for livestock don’t want extra hurdles—they want healthy herds. Opening access to medicines like Imidocarb Dipropionate without oversight wouldn’t work out well for animals, their caretakers, or future customers eating those animals. Real progress means keeping animal health front and center, working side-by-side with animal health experts. In my experience, asking for help got us farther than risking it alone.
Anyone who’s spent time working with animals—horses, dogs, livestock, doesn’t matter—knows medicine goes far beyond picking up a bottle and hoping for the best. Imidocarb Dipropionate, or Imidocarb Bispropionate as it’s called in some circles, plays a big role for veterinarians dealing with blood parasites like babesiosis. Messing up how this injectable gets stored creates headaches fast: not only do the drugs lose their punch, your animals could wind up sicker.
Drug companies make these compounds in sterile vials, protecting them from air, light, and moisture. Temperature swings complicate things for this drug. Even a short stint sitting in a truck cab or barn, especially during a hot spell, can make imidocarb break down much faster than you expect. Chemistry changes, solution clouds up, crystallization starts forming at the bottom of the vial. Giving that to a sick animal turns a potential cure into a risk.
Drug labels don’t get printed for fun. On every genuine package from a reputable manufacturer, “store at 2°C to 8°C”—which is the range you find inside a good refrigerator. Not in the freezer, not out on a counter. Letting it freeze damages the suspension. Letting it warm up weakens it, especially over weeks.
A refrigerator that holds a reliable, steady temperature keeps this medication in top shape. Don’t stash it on the fridge door. Pick a consistent shelf away from the back, since freezing sometimes creeps along those back walls. Write the date you open the vial somewhere visible. Even if the label says it can last for a certain time after the first use, using common sense trumps printed text. If liquid turns cloudy or you see clumps, it’s safer to throw it out and get a new vial.
Out on the ranch or in a busy practice, someone forgets a bottle in the glovebox for a couple afternoons. Or maybe the power goes out, and the fridge gives out. I’ve seen people think, “It’s just a day, what could go wrong?” Then animals don’t bounce back after what should’ve been a sure fix.
Many cases of medicine failure trace back to sloppy storage. Veterinary studies back this up. A 2021 review published in the Journal of Veterinary Pharmacology found that improper storage conditions caused measurable loss of potency and even contributed to heightened risk of adverse reactions—not something any animal caretaker should gamble with.
Writing down what goes into a fridge isn’t only for scientists. Even small clinics and farm managers benefit from lists stuck on the door, with dates and lot numbers. Everybody on the crew should know which shelf is for imidocarb and which bottles are safe to use. Keeping a backup generator for fridges cuts down on the anxiety when storms blow through and power lines drop.
Drug reps and veterinarians offer help—don’t hesitate to ask for advice on keeping the setup solid. Manufacturers have toll-free hotlines and websites with up-to-date guides, so no one works in the dark.
I tell clients it’s not about being perfect every time, but caring enough not to take shortcuts. Storing medicines the right way means giving every animal a better shot at getting healthy—and saving money at the same time.
| Names | |
| Preferred IUPAC name | Propanoic acid; 3,3'-[[(1,3-phenylene)bis(carbonylimino)]bis(methylene)]bis(1-propylurea) |
| Other names |
Imidocarbe Imidocarb Imizol Imidocarb dipropionate Imidocarb bispropionate |
| Pronunciation | /ɪˌmɪd.oʊˈkɑːrb ˌdaɪˌproʊˈpiːəˌneɪt/ |
| Identifiers | |
| CAS Number | 55750-06-6 |
| 3D model (JSmol) | `Imidocarb Dipropionate JSmol string: CN(CCNC(=N)N)C(=N)N.CC(C)C(=O)O.CC(C)C(=O)O` |
| Beilstein Reference | 3578731 |
| ChEBI | CHEBI:81941 |
| ChEMBL | CHEMBL2108501 |
| ChemSpider | 126502 |
| DrugBank | DB11559 |
| ECHA InfoCard | 100.073.126 |
| EC Number | 3.5.2.6 |
| Gmelin Reference | 80187 |
| KEGG | C18737 |
| MeSH | D017957 |
| PubChem CID | 656774 |
| RTECS number | BP9395000 |
| UNII | 9ME6W8E76K |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID3031972 |
| Properties | |
| Chemical formula | C19H24N6O2(C3H6O2)2 |
| Molar mass | 572.7 g/mol |
| Appearance | A white or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.206 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -2.0 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 10.2 |
| Basicity (pKb) | 8.30 |
| Magnetic susceptibility (χ) | -4.9 × 10⁻⁶ cm³/mol |
| Viscosity | Viscous liquid |
| Dipole moment | 5.70 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 243.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | QG51BA01 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes damage to organs through prolonged or repeated exposure. |
| GHS labelling | GHS05, GHS06, GHS08, Danger, H301, H311, H331, H351, H373, H314 |
| Pictograms | GHS06,GHS08 |
| Signal word | Warning |
| Hazard statements | Harmful if swallowed. Causes damage to organs through prolonged or repeated exposure. May cause allergic skin reaction. |
| Precautionary statements | P201, P202, P260, P264, P270, P271, P272, P273, P280, P284, P301+P310, P302+P352, P304+P340, P308+P313, P314, P320, P330, P501 |
| NFPA 704 (fire diamond) | Health: 3, Flammability: 1, Instability: 0, Special: - |
| Lethal dose or concentration | LD50 (rat, oral): 130 mg/kg |
| LD50 (median dose) | LD50 (median dose): 130 mg/kg (rat, intravenous) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1 mg/kg IM or SC every 2 weeks |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Imidocarb Imidocarb hydrochloride |
